Features
Unique 3-add CooperVision® Binocular Progressive SystemTM
Fit 98% of patients with two pairs of lenses or fewer 1,2 when following the MyDay® multifocal fitting guide or OptiExpertTM
The greatest parameter range of any one-day multifocal contact lens3
Incredible all-day comfort through Aquaform® Technology*
High Dk/t allows 100% of oxygen to reach the eyes6
The CooperVision® Binocular Progressive System™ - an evolution in multifocal 1-day lens design system
Introducing a unique and innovative 3-add multifocal system in a 1-day lens. Unlike most one-day multifocal systems which rely on similar optical designs across each add power, just strengthening the power profile to increase reading support, the CooperVision® Binocular Progressive System™ utilises different lens designs to optimise vision for all levels of presbyopia.1 Designed to help newly presbyopic patients adapt to multifocal contact lens wear and allow patients to enjoy clear vision as their presbyopia advances.
Easy and successful fitting1,2 supported by OptiExpert™
Allows you to successfully fit 98% of patients with two pairs of lenses or fewer.1,2 when using the MyDay® multifocal fitting guide or OptiExpert™. The OptiExpertTM smart prescription calculator helps support your decision-making – just input the spectacle power. Can help you save valuable chair time by accurately recommending multifocal contact lens powers.7,8
Aquaform® Technology – the science behind unsurpassed comfort.
MyDay® multifocal lenses utilise Aquaform® Technology - as found in Biofinity® - to create a naturally wettable lens that delivers incredible long-lasting comfort. The technologically advanced silicone channels in the MyDay® material transport oxygen so efficiently that less raw silicon is required. This sustains inherent wettability and facilitates optimal water content.
- Long-chain silicone – up to four times the Dk/t of some other hydrogel daily disposable contact lenses for a healthier lens-wearing experience.
- Molecularly-bonded hydrophilic groups – sustained water content for long-lasting comfort.
- Less raw silicon – a more flexible lens for our softest-ever one-day lens**, yet easy to handle.
Talk to your presbyopic patients about the exceptional vision, unsurpassed comfort and healthy wearing experience of MyDay® multifocal contact lenses - an excellent choice for new patients who demand no compromise, and an easy upgrade for your current hydrogel one-day multifocal lens wearers.
Lens Technology
Product Details
Mid (+1.50D to +1.75D Spectacle Rx add)
High (+2.00D to +2.50D Spectacle Rx add)
* Available from November 2021
†Warning: UV blocking contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
References:
1. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers.
2. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® daily disposable multifocal; n=104 habitual multifocal contact lens wearers; CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® daily disposable multifocal; n=58 habitual multifocal contact lens wearers.
3. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers.
4. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study with MyDay® multifocal; n=104 habitual MFCL wearers.
5. REF: Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472.]
6. Brennan NA. Beyond Flux: Total Corneal Oxygen Consumption as an Index of Corneal Oxygenation During Contact Lens Wear. Optom Vis Sci. 2005;82(6):467-472.
7. CVI data on file 2019. Retrospective analysis; N=55 subjects (110 eyes); DV Rx +1.25D to -3.25D, add powers +1.25 to +2.50DS.
8. CVI data on file 2018. Based on retrospective analysis of 26 patients (52 eyes) with subjective refractions ranging between +5.00D to -6.00D and ≤ -1.00 D cylinder.